Skip to main content
Top
Published in: Acta Diabetologica 2/2018

Open Access 01-02-2018 | Original Article

Association between multimorbidity and mean platelet volume in diabetic patients with acute myocardial infarction

Authors: Bartosz Hudzik, Ilona Korzonek-Szlacheta, Janusz Szkodziński, Radosław Liszka, Andrzej Lekston, Barbara Zubelewicz-Szkodzińska, Mariusz Gąsior

Published in: Acta Diabetologica | Issue 2/2018

Login to get access

Abstract

Aims

Diabetes mellitus (DM) is one of the most frequently detected conditions in multimorbid disease clusters. Platelet activation is one of the key mechanisms underlying atherothrombosis in acute myocardial infarction. Available data link mean platelet volume (MPV) to poor prognosis not only in cardiovascular and non-cardiovascular disease. Given the lack of research data on the association between disease clusters and MPV, we have set out to investigate the link between multimorbidity and MPV in diabetic patients with acute myocardial infarction.

Methods

A total of 277 patients with DM and STEMI undergoing primary percutaneous coronary intervention were enrolled. Based on the number of comorbidities the study population was divided into two groups: group 1 (N = 58) with ≤ 1 comorbidity and group 2 (N = 219) with ≥ 2 comorbidities. A subanalysis was performed within the multimorbidity group: group 2A with two or three comorbidities (N = 156) and group 2B with at least four comorbidities (N = 63).

Results

In the study population, 15.9% of patients had one comorbidity, and 22.0, 34.3, and 22.7% of patients had two, three, or at least four comorbid conditions, respectively. Both MPV and PDW were elevated in multimorbid patients (9.3 vs 10.8 fl and 9.5 vs 10.3 fl, respectively). The highest platelet volume indices were observed in patients with at least four comorbid conditions. There was a moderate positive correlation between MPV and the total number of comorbidities, the number of CVD comorbidities, and the number of non-CVD comorbidities.

Conclusions

These findings indicate that multimorbidity is associated with an increase in platelet volume indices. MPV values increased with the increasing number of comorbid conditions. Importantly, MPV values were elevated in some, but not all CVD and non-CVD conditions.
Literature
2.
go back to reference Druss BG, Marcus SC, Olfson M, Tanielian T, Elinson L, Pincus HA (2001) Comparing the national economic burden of five chronic conditions. Health Aff (Millwood) 20:233–241CrossRef Druss BG, Marcus SC, Olfson M, Tanielian T, Elinson L, Pincus HA (2001) Comparing the national economic burden of five chronic conditions. Health Aff (Millwood) 20:233–241CrossRef
3.
go back to reference Wolff JL, Starfield B, Anderson G (2002) Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med 162:2269–2276CrossRefPubMed Wolff JL, Starfield B, Anderson G (2002) Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med 162:2269–2276CrossRefPubMed
4.
go back to reference Diederichs C, Berger K, Bartels DB (2011) The measurement of multiple chronic diseases–a systematic review on existing multimorbidity indices. J Gerontol A Biol Sci Med Sci 66:301–311CrossRefPubMed Diederichs C, Berger K, Bartels DB (2011) The measurement of multiple chronic diseases–a systematic review on existing multimorbidity indices. J Gerontol A Biol Sci Med Sci 66:301–311CrossRefPubMed
5.
go back to reference Teljeur C, Smith SM, Paul G, Kelly A, O’Dowd T (2013) Multimorbidity in a cohort of patients with type 2 diabetes. Eur J Gen Pract 19:17–22CrossRefPubMed Teljeur C, Smith SM, Paul G, Kelly A, O’Dowd T (2013) Multimorbidity in a cohort of patients with type 2 diabetes. Eur J Gen Pract 19:17–22CrossRefPubMed
7.
go back to reference Marzona I, Avanzini F, Lucisano G et al (2017) Are all people with diabetes and cardiovascular risk factors or microvascular complications at very high risk? Findings from the Risk and Prevention Study. Acta Diabetol 54:123–131CrossRefPubMed Marzona I, Avanzini F, Lucisano G et al (2017) Are all people with diabetes and cardiovascular risk factors or microvascular complications at very high risk? Findings from the Risk and Prevention Study. Acta Diabetol 54:123–131CrossRefPubMed
8.
go back to reference Hudzik B, Szkodzinski J, Hawranek M, Lekston A, Polonski L, Gasior M (2016) CHA2DS2-VASc score is useful in predicting poor 12-month outcomes following myocardial infarction in diabetic patients without atrial fibrillation. Acta Diabetol 53:807–815CrossRefPubMedPubMedCentral Hudzik B, Szkodzinski J, Hawranek M, Lekston A, Polonski L, Gasior M (2016) CHA2DS2-VASc score is useful in predicting poor 12-month outcomes following myocardial infarction in diabetic patients without atrial fibrillation. Acta Diabetol 53:807–815CrossRefPubMedPubMedCentral
9.
go back to reference Lynch CP, Gebregziabher M, Axon RN, Hunt KE, Payne E, Egede LE (2015) Geographic and racial/ethnic variations in patterns of multimorbidity burden in patients with type 2 diabetes. J Gen Intern Med 30:25–32CrossRefPubMed Lynch CP, Gebregziabher M, Axon RN, Hunt KE, Payne E, Egede LE (2015) Geographic and racial/ethnic variations in patterns of multimorbidity burden in patients with type 2 diabetes. J Gen Intern Med 30:25–32CrossRefPubMed
10.
go back to reference Alonso-Moran E, Orueta JF, Fraile Esteban JI et al (2014) The prevalence of diabetes-related complications and multimorbidity in the population with type 2 diabetes mellitus in the Basque Country. BMC Public Health 14:1059CrossRefPubMedPubMedCentral Alonso-Moran E, Orueta JF, Fraile Esteban JI et al (2014) The prevalence of diabetes-related complications and multimorbidity in the population with type 2 diabetes mellitus in the Basque Country. BMC Public Health 14:1059CrossRefPubMedPubMedCentral
11.
go back to reference Lin PJ, Kent DM, Winn A, Cohen JT, Neumann PJ (2015) Multiple chronic conditions in type 2 diabetes mellitus: prevalence and consequences. Am J Manag Care 21:e23–e34PubMed Lin PJ, Kent DM, Winn A, Cohen JT, Neumann PJ (2015) Multiple chronic conditions in type 2 diabetes mellitus: prevalence and consequences. Am J Manag Care 21:e23–e34PubMed
12.
go back to reference Valettas N, Herrmann HC (2003) The role of platelets and platelet inhibition in acute myocardial infarction. Coron Artery Dis 14:357–363PubMed Valettas N, Herrmann HC (2003) The role of platelets and platelet inhibition in acute myocardial infarction. Coron Artery Dis 14:357–363PubMed
13.
go back to reference Ferreiro JL, Angiolillo DJ (2011) Diabetes and antiplatelet therapy in acute coronary syndrome. Circulation 123:798–813CrossRefPubMed Ferreiro JL, Angiolillo DJ (2011) Diabetes and antiplatelet therapy in acute coronary syndrome. Circulation 123:798–813CrossRefPubMed
14.
15.
go back to reference Leader A, Pereg D, Lishner M (2012) Are platelet volume indices of clinical use? A multidisciplinary review. Ann Med 44:805–816CrossRefPubMed Leader A, Pereg D, Lishner M (2012) Are platelet volume indices of clinical use? A multidisciplinary review. Ann Med 44:805–816CrossRefPubMed
16.
go back to reference Hekimsoy Z, Payzin B, Ornek T, Kandogan G (2004) Mean platelet volume in Type 2 diabetic patients. J Diabetes Complicat 18:173–176CrossRefPubMed Hekimsoy Z, Payzin B, Ornek T, Kandogan G (2004) Mean platelet volume in Type 2 diabetic patients. J Diabetes Complicat 18:173–176CrossRefPubMed
17.
go back to reference Coban E, Bostan F, Ozdogan M (2006) The mean platelet volume in subjects with impaired fasting glucose. Platelets 17:67–69CrossRefPubMed Coban E, Bostan F, Ozdogan M (2006) The mean platelet volume in subjects with impaired fasting glucose. Platelets 17:67–69CrossRefPubMed
18.
go back to reference Coban E, Afacan B (2008) The effect of rosuvastatin treatment on the mean platelet volume in patients with uncontrolled primary dyslipidemia with hypolipidemic diet treatment. Platelets 19:111–114CrossRefPubMed Coban E, Afacan B (2008) The effect of rosuvastatin treatment on the mean platelet volume in patients with uncontrolled primary dyslipidemia with hypolipidemic diet treatment. Platelets 19:111–114CrossRefPubMed
19.
go back to reference Demirtunc R, Duman D, Basar M, Bilgi M, Teomete M, Garip T (2009) The relationship between glycemic control and platelet activity in type 2 diabetes mellitus. J Diabetes Complicat 23:89–94CrossRefPubMed Demirtunc R, Duman D, Basar M, Bilgi M, Teomete M, Garip T (2009) The relationship between glycemic control and platelet activity in type 2 diabetes mellitus. J Diabetes Complicat 23:89–94CrossRefPubMed
20.
go back to reference Huczek Z, Kochman J, Filipiak KJ et al (2005) Mean platelet volume on admission predicts impaired reperfusion and long-term mortality in acute myocardial infarction treated with primary percutaneous coronary intervention. J Am Coll Cardiol 46:284–290CrossRefPubMed Huczek Z, Kochman J, Filipiak KJ et al (2005) Mean platelet volume on admission predicts impaired reperfusion and long-term mortality in acute myocardial infarction treated with primary percutaneous coronary intervention. J Am Coll Cardiol 46:284–290CrossRefPubMed
21.
go back to reference Lekston A, Hudzik B, Hawranek M et al (2014) Prognostic significance of mean platelet volume in diabetic patients with ST-elevation myocardial infarction. J Diabetes Complicat 28:652–657CrossRefPubMed Lekston A, Hudzik B, Hawranek M et al (2014) Prognostic significance of mean platelet volume in diabetic patients with ST-elevation myocardial infarction. J Diabetes Complicat 28:652–657CrossRefPubMed
22.
go back to reference Tasci I, Basgoz BB, Saglam K (2016) Glycemic control and the risk of microvascular complications in people with diabetes mellitus. Acta Diabetol 53:129–130CrossRefPubMed Tasci I, Basgoz BB, Saglam K (2016) Glycemic control and the risk of microvascular complications in people with diabetes mellitus. Acta Diabetol 53:129–130CrossRefPubMed
23.
go back to reference Anjana RM, Amutha A, Mohan V (2016) Regularity of follow-up, glycemic burden, and risk of microvascular complications in patients with type 2 diabetes: a 9-year follow-up study. Acta Diabetol 53:131–132CrossRefPubMed Anjana RM, Amutha A, Mohan V (2016) Regularity of follow-up, glycemic burden, and risk of microvascular complications in patients with type 2 diabetes: a 9-year follow-up study. Acta Diabetol 53:131–132CrossRefPubMed
24.
go back to reference Papanas N, Symeonidis G, Maltezos E et al (2004) Mean platelet volume in patients with type 2 diabetes mellitus. Platelets 15:475–478CrossRefPubMed Papanas N, Symeonidis G, Maltezos E et al (2004) Mean platelet volume in patients with type 2 diabetes mellitus. Platelets 15:475–478CrossRefPubMed
25.
go back to reference Pyo JS, Sohn JH, Kang G (2016) Diagnostic and prognostic roles of the mean platelet volume in malignant tumors: a systematic review and meta-analysis. Platelets 27:722–728CrossRefPubMed Pyo JS, Sohn JH, Kang G (2016) Diagnostic and prognostic roles of the mean platelet volume in malignant tumors: a systematic review and meta-analysis. Platelets 27:722–728CrossRefPubMed
26.
go back to reference Steiropoulos P, Papanas N, Nena E, Xanthoudaki M, Goula T, Froudarakis M, Pita E, Maltezos E, Bouros D (2013) Mean platelet volume and platelet distribution width in patients with chronic obstructive pulmonary disease: the role of comorbidities. Angiology 64:535–539CrossRefPubMed Steiropoulos P, Papanas N, Nena E, Xanthoudaki M, Goula T, Froudarakis M, Pita E, Maltezos E, Bouros D (2013) Mean platelet volume and platelet distribution width in patients with chronic obstructive pulmonary disease: the role of comorbidities. Angiology 64:535–539CrossRefPubMed
27.
go back to reference Ju HY, Kim JK, Hur SM et al (2015) Could mean platelet volume be a promising biomarker of progression of chronic kidney disease? Platelets 26:143–147CrossRefPubMed Ju HY, Kim JK, Hur SM et al (2015) Could mean platelet volume be a promising biomarker of progression of chronic kidney disease? Platelets 26:143–147CrossRefPubMed
28.
go back to reference Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD (2011) Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des 17:47–58CrossRefPubMed Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD (2011) Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des 17:47–58CrossRefPubMed
29.
go back to reference Hudzik B, Szkodzinski J, Gorol J et al (2015) Platelet-to-lymphocyte ratio is a marker of poor prognosis in patients with diabetes mellitus and ST-elevation myocardial infarction. Biomark Med 9:199–207CrossRefPubMed Hudzik B, Szkodzinski J, Gorol J et al (2015) Platelet-to-lymphocyte ratio is a marker of poor prognosis in patients with diabetes mellitus and ST-elevation myocardial infarction. Biomark Med 9:199–207CrossRefPubMed
30.
go back to reference Nguyen HL, Nguyen QN, Ha DA, Phan DT, Nguyen NH, Goldberg RJ (2014) Prevalence of comorbidities and their impact on hospital management and short-term outcomes in Vietnamese patients hospitalized with a first acute myocardial infarction. PLoS ONE 9:e108998CrossRefPubMedPubMedCentral Nguyen HL, Nguyen QN, Ha DA, Phan DT, Nguyen NH, Goldberg RJ (2014) Prevalence of comorbidities and their impact on hospital management and short-term outcomes in Vietnamese patients hospitalized with a first acute myocardial infarction. PLoS ONE 9:e108998CrossRefPubMedPubMedCentral
31.
go back to reference McManus DD, Nguyen HL, Saczynski JS, Tisminetzky M, Bourell P, Goldberg RJ (2012) Multiple cardiovascular comorbidities and acute myocardial infarction: temporal trends (1990–2007) and impact on death rates at 30 days and 1 year. Clin Epidemiol 4:115–123PubMedPubMedCentral McManus DD, Nguyen HL, Saczynski JS, Tisminetzky M, Bourell P, Goldberg RJ (2012) Multiple cardiovascular comorbidities and acute myocardial infarction: temporal trends (1990–2007) and impact on death rates at 30 days and 1 year. Clin Epidemiol 4:115–123PubMedPubMedCentral
32.
go back to reference Schmidt M, Jacobsen JB, Lash TL, Botker HE, Sorensen HT (2012) 25 year trends in first time hospitalisation for acute myocardial infarction, subsequent short and long term mortality, and the prognostic impact of sex and comorbidity: a Danish nationwide cohort study. BMJ 344:e356CrossRefPubMedPubMedCentral Schmidt M, Jacobsen JB, Lash TL, Botker HE, Sorensen HT (2012) 25 year trends in first time hospitalisation for acute myocardial infarction, subsequent short and long term mortality, and the prognostic impact of sex and comorbidity: a Danish nationwide cohort study. BMJ 344:e356CrossRefPubMedPubMedCentral
33.
go back to reference Chen HY, Saczynski JS, McManus DD et al (2013) The impact of cardiac and noncardiac comorbidities on the short-term outcomes of patients hospitalized with acute myocardial infarction: a population-based perspective. Clin Epidemiol 5:439–448PubMedPubMedCentral Chen HY, Saczynski JS, McManus DD et al (2013) The impact of cardiac and noncardiac comorbidities on the short-term outcomes of patients hospitalized with acute myocardial infarction: a population-based perspective. Clin Epidemiol 5:439–448PubMedPubMedCentral
34.
go back to reference Smith SM, Soubhi H, Fortin M, Hudon C, O’Dowd T (2012) Managing patients with multimorbidity: systematic review of interventions in primary care and community settings. BMJ 345:e5205CrossRefPubMedPubMedCentral Smith SM, Soubhi H, Fortin M, Hudon C, O’Dowd T (2012) Managing patients with multimorbidity: systematic review of interventions in primary care and community settings. BMJ 345:e5205CrossRefPubMedPubMedCentral
36.
go back to reference van den Akker M, Buntinx F, Metsemakers JF, Roos S, Knottnerus JA (1998) Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases. J Clin Epidemiol 51:367–375CrossRefPubMed van den Akker M, Buntinx F, Metsemakers JF, Roos S, Knottnerus JA (1998) Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases. J Clin Epidemiol 51:367–375CrossRefPubMed
37.
go back to reference World Health Organization. Innovative care for chronic conditions: building blocks for action. Global report. World Health Organization. World Health Organization. Innovative care for chronic conditions: building blocks for action. Global report. World Health Organization.
38.
go back to reference Friedman EM, Christ SL, Mroczek DK (2015) inflammation partially mediates the association of multimorbidity and functional limitations in a national sample of middle-aged and older adults: the MIDUS study. J Aging Health 27:843–863CrossRefPubMedPubMedCentral Friedman EM, Christ SL, Mroczek DK (2015) inflammation partially mediates the association of multimorbidity and functional limitations in a national sample of middle-aged and older adults: the MIDUS study. J Aging Health 27:843–863CrossRefPubMedPubMedCentral
39.
go back to reference Bautista LE, Vera LM, Arenas IA, Gamarra G (2005) Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-alpha) and essential hypertension. J Hum Hypertens 19:149–154CrossRefPubMed Bautista LE, Vera LM, Arenas IA, Gamarra G (2005) Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-alpha) and essential hypertension. J Hum Hypertens 19:149–154CrossRefPubMed
40.
go back to reference Blake GJ, Ridker PM (2003) C-reactive protein and other inflammatory risk markers in acute coronary syndromes. J Am Coll Cardiol 41:37S–42SCrossRefPubMed Blake GJ, Ridker PM (2003) C-reactive protein and other inflammatory risk markers in acute coronary syndromes. J Am Coll Cardiol 41:37S–42SCrossRefPubMed
41.
go back to reference Hu FB, Meigs JB, Li TY, Rifai N, Manson JE (2004) Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes 53:693–700CrossRefPubMed Hu FB, Meigs JB, Li TY, Rifai N, Manson JE (2004) Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes 53:693–700CrossRefPubMed
42.
go back to reference Fabbri E, An Y, Zoli M et al (2015) Aging and the burden of multimorbidity: associations with inflammatory and anabolic hormonal biomarkers. J Gerontol A Biol Sci Med Sci 70:63–70CrossRefPubMed Fabbri E, An Y, Zoli M et al (2015) Aging and the burden of multimorbidity: associations with inflammatory and anabolic hormonal biomarkers. J Gerontol A Biol Sci Med Sci 70:63–70CrossRefPubMed
43.
45.
go back to reference Phipps RP (2011) Platelets at the interface between thrombosis, inflammation and immunity. Thromb Res 127:179CrossRefPubMed Phipps RP (2011) Platelets at the interface between thrombosis, inflammation and immunity. Thromb Res 127:179CrossRefPubMed
46.
go back to reference Wagner DD, Burger PC (2003) Platelets in inflammation and thrombosis. Arterioscler Thromb Vasc Biol 23:2131–2137CrossRefPubMed Wagner DD, Burger PC (2003) Platelets in inflammation and thrombosis. Arterioscler Thromb Vasc Biol 23:2131–2137CrossRefPubMed
47.
go back to reference Kaushansky K (1998) Growth factors and hematopoietic cell fate. A new feature: controversies in hematology. Blood 92:344–345 Kaushansky K (1998) Growth factors and hematopoietic cell fate. A new feature: controversies in hematology. Blood 92:344–345
48.
go back to reference Brown AS, Hong Y, de Belder A et al (1997) Megakaryocyte ploidy and platelet changes in human diabetes and atherosclerosis. Arterioscler Thromb Vasc Biol 17:802–807CrossRefPubMed Brown AS, Hong Y, de Belder A et al (1997) Megakaryocyte ploidy and platelet changes in human diabetes and atherosclerosis. Arterioscler Thromb Vasc Biol 17:802–807CrossRefPubMed
49.
go back to reference Arikanoglu A, Yucel Y, Acar A, Cevik MU, Akil E, Varol S (2013) The relationship of the mean platelet volume and C-reactive protein levels with mortality in ischemic stroke patients. Eur Rev Med Pharmacol Sci 17:1774–1777PubMed Arikanoglu A, Yucel Y, Acar A, Cevik MU, Akil E, Varol S (2013) The relationship of the mean platelet volume and C-reactive protein levels with mortality in ischemic stroke patients. Eur Rev Med Pharmacol Sci 17:1774–1777PubMed
50.
go back to reference Magen E, Mishal J, Zeldin Y et al (2010) Increased mean platelet volume and C-reactive protein levels in patients with chronic urticaria with a positive autologous serum skin test. Am J Med Sci 339:504–508CrossRefPubMed Magen E, Mishal J, Zeldin Y et al (2010) Increased mean platelet volume and C-reactive protein levels in patients with chronic urticaria with a positive autologous serum skin test. Am J Med Sci 339:504–508CrossRefPubMed
51.
go back to reference Erdem K, Ayhan S, Ozturk S et al (2014) Usefulness of the mean platelet volume for predicting new-onset atrial fibrillation after isolated coronary artery bypass grafting. Platelets 25:23–26CrossRefPubMed Erdem K, Ayhan S, Ozturk S et al (2014) Usefulness of the mean platelet volume for predicting new-onset atrial fibrillation after isolated coronary artery bypass grafting. Platelets 25:23–26CrossRefPubMed
52.
go back to reference Moon AR, Choi DH, Jahng SY et al (2016) High-sensitivity C-reactive protein and mean platelet volume as predictive values after percutaneous coronary intervention for long-term clinical outcomes: a comparable and additive study. Blood Coagul Fibrinolysis 27:70–76CrossRefPubMed Moon AR, Choi DH, Jahng SY et al (2016) High-sensitivity C-reactive protein and mean platelet volume as predictive values after percutaneous coronary intervention for long-term clinical outcomes: a comparable and additive study. Blood Coagul Fibrinolysis 27:70–76CrossRefPubMed
53.
go back to reference Kim D, Choi DH, Kim BB, Choi SW, Park KH, Song H (2016) Prediction of Infarct Transmurality From C-Reactive Protein Level and Mean Platelet Volume in Patients With ST-Elevation Myocardial Infarction: comparison of the Predictive Values of Cardiac Enzymes. J Clin Lab Anal 30:930–940CrossRefPubMed Kim D, Choi DH, Kim BB, Choi SW, Park KH, Song H (2016) Prediction of Infarct Transmurality From C-Reactive Protein Level and Mean Platelet Volume in Patients With ST-Elevation Myocardial Infarction: comparison of the Predictive Values of Cardiac Enzymes. J Clin Lab Anal 30:930–940CrossRefPubMed
55.
go back to reference Agapakis DI, Massa EV, Hantzis I et al (2016) The role of mean platelet volume in chronic obstructive pulmonary disease exacerbation. Respir Care 61:44–49CrossRefPubMed Agapakis DI, Massa EV, Hantzis I et al (2016) The role of mean platelet volume in chronic obstructive pulmonary disease exacerbation. Respir Care 61:44–49CrossRefPubMed
56.
go back to reference Wasilewska A, Tenderenda E, Taranta-Janusz K, Zoch-Zwierz W (2010) High-sensitivity C-reactive protein and mean platelet volume in paediatric hypertension. Pediatr Nephrol 25:1519–1527CrossRefPubMed Wasilewska A, Tenderenda E, Taranta-Janusz K, Zoch-Zwierz W (2010) High-sensitivity C-reactive protein and mean platelet volume in paediatric hypertension. Pediatr Nephrol 25:1519–1527CrossRefPubMed
57.
go back to reference Yazici S, Yazici M, Erer B, Calik Y, Ozhan H, Ataoglu S (2010) The platelet indices in patients with rheumatoid arthritis: mean platelet volume reflects disease activity. Platelets 21:122–125CrossRefPubMed Yazici S, Yazici M, Erer B, Calik Y, Ozhan H, Ataoglu S (2010) The platelet indices in patients with rheumatoid arthritis: mean platelet volume reflects disease activity. Platelets 21:122–125CrossRefPubMed
58.
go back to reference Tasoglu O, Sahin A, Karatas G, Koyuncu E, Tasoglu I, Tecimel O, Ozgirgin N (2017) Blood mean platelet volume and platelet lymphocyte ratio as new predictors of hip osteoarthritis severity. Medicine (Baltimore) 96:e6073CrossRef Tasoglu O, Sahin A, Karatas G, Koyuncu E, Tasoglu I, Tecimel O, Ozgirgin N (2017) Blood mean platelet volume and platelet lymphocyte ratio as new predictors of hip osteoarthritis severity. Medicine (Baltimore) 96:e6073CrossRef
59.
go back to reference Lee JH, Yoon SY, Kim HS, Lim CS (2015) Characteristics of the mean platelet volume, neutrophil to lymphocyte ratio, and C-reactive protein compared to the procalcitonin level in pneumonia patients. Platelets 26:278–280CrossRefPubMed Lee JH, Yoon SY, Kim HS, Lim CS (2015) Characteristics of the mean platelet volume, neutrophil to lymphocyte ratio, and C-reactive protein compared to the procalcitonin level in pneumonia patients. Platelets 26:278–280CrossRefPubMed
60.
go back to reference Kisacik B, Tufan A, Kalyoncu U et al (2008) Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis. Joint Bone Spine 75:291–294CrossRefPubMed Kisacik B, Tufan A, Kalyoncu U et al (2008) Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis. Joint Bone Spine 75:291–294CrossRefPubMed
61.
go back to reference Kapsoritakis AN, Koukourakis MI, Sfiridaki A et al (2001) Mean platelet volume: a useful marker of inflammatory bowel disease activity. Am J Gastroenterol 96:776–781CrossRefPubMed Kapsoritakis AN, Koukourakis MI, Sfiridaki A et al (2001) Mean platelet volume: a useful marker of inflammatory bowel disease activity. Am J Gastroenterol 96:776–781CrossRefPubMed
62.
go back to reference Delgado-Garcia G, Galarza-Delgado DA, Colunga-Pedraza I et al (2016) Mean platelet volume is decreased in adults with active lupus disease. Rev Bras Reumatol Engl Ed. 56:504–508CrossRefPubMed Delgado-Garcia G, Galarza-Delgado DA, Colunga-Pedraza I et al (2016) Mean platelet volume is decreased in adults with active lupus disease. Rev Bras Reumatol Engl Ed. 56:504–508CrossRefPubMed
Metadata
Title
Association between multimorbidity and mean platelet volume in diabetic patients with acute myocardial infarction
Authors
Bartosz Hudzik
Ilona Korzonek-Szlacheta
Janusz Szkodziński
Radosław Liszka
Andrzej Lekston
Barbara Zubelewicz-Szkodzińska
Mariusz Gąsior
Publication date
01-02-2018
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 2/2018
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-017-1079-6

Other articles of this Issue 2/2018

Acta Diabetologica 2/2018 Go to the issue